Debut trading of Recursion Pharmaceuticals, Inc.

In its debut trading on Friday, April 16 Recursion Pharmaceuticals, Inc. (RXRX) closed at $31.30 per share, which is 73.89% above the offering price. Shortly before the company had placed its shares in an IPO priced $18 per share.